Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $3
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen has initiated coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and set a price target of $3.
November 28, 2023 | 4:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Envoy Medical has been given a Buy rating and a price target of $3 by Lake Street analyst Frank Takkinen.
The initiation of coverage by an analyst with a Buy rating typically indicates a positive outlook on the stock's future performance. The price target of $3 suggests a potential upside from the current trading price. This can lead to increased investor interest and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100